<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">PRAZIQUANTEL</span><br/>(pray-zi-kwon'tel)<br/><span class="topboxtradename">Biltricide<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">anthelmintic</span><br/><b>Prototype: </b>Mebendazole<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>600 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic agent with broad-spectrum anthelmintic activity against all developmental stages of schistosomes and other trematodes
         (flukes) and against cestodes (tapeworm). Increases permeability of parasite cell membrane to calcium. Leads to immobilization
         of their suckers and dislodgment from their residence in blood vessel walls.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Active against all developmental stages of schistosomes, including cercaria (free-swimming larvae). Activity against other
         trematodes (flukes) not fully understood; activity against cestodes (tapeworms) not clear but may be similar to that against
         schistosomes.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>All stages of schistosomiasis (bilharziasis) caused by all schistosoma species pathogenic to humans. Other trematode infections
         caused by Chinese liver fluke.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Lung, sheep liver, and intestinal flukes and tapeworm infections.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to drug; ocular cysticercosis. Safety in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Schistosomiasis</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">PO</span> &gt;<i>4 y</i>, 60 mg/kg in 3 equally divided doses at 46 h intervals on the same day, may repeat in 23 mo after exposure<br/><br/><span class="indicationtitle">Other Trematodes</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">PO</span> &gt;<i>4 y</i>, 75 mg/kg in 3 equally divided doses at 46 h intervals on the same day<br/><br/><span class="indicationtitle">Cestodiasis (Adult or Intestinal Stage)</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1020 mg/kg as single dose<br/><br/><span class="indicationtitle">Cestodiasis (Larval or Tissue Stage)</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 50 mg/kg in 3 divided doses/d for 14 d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give dose with food and fluids. Tablets can be broken into quarters but should <small>NOT</small> be chewed.
         </li>
<li>Advise patient to take sufficient fluid to wash down the medication. Tablets are soluble in water; gagging or vomiting because
            of bitter taste may result if tablets are retained in the mouth.
         </li>
<li>Treatment for cestodiasis (tapeworm) is followed by gentle purgation 2 h after drug administration to facilitate rapid removal
            of tapeworms and ova.
         </li>
<li>Store tablets in tight containers at 
      </li></ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> <span class="speceff-common">Dizziness, headache, malaise,</span> drowsiness, lassitude, <span class="speceff-life">CSF reaction syndrome</span> (exacerbation of neurologic signs and symptoms such as seizures, increased CSF protein concentration, increased anticysticercal
      IgG levels, hyperthermia, intracranial hypertension) in patient treated for cerebral cysticercosis. <span class="typehead">GI:</span> <span class="speceff-common">Abdominal pain or discomfort with or without nausea;</span> vomiting, anorexia, diarrhea. <span class="typehead">Hepatic:</span> <span class="speceff-common">Increased AST, ALT (slight).</span> <span class="typehead">Skin:</span> Pruritus, urticaria. <span class="typehead">Body as a Whole:</span> Fever, sweating, symptoms of host-mediated immunologic response to antigen release from worms (fever, eosinophilia). 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>Be mindful that selected drugs may interfere with stool studies for ova and parasites: <span class="alt">iron,</span> <span class="alt">bismuth,</span> <span class="alt">oil</span> (<span class="alt">mineral</span> or <span class="alt">castor</span>), <span class="alt">Metamucil</span> (if ingested within 1 wk of test), <span class="alt">barium,</span> <span class="alt">antibiotics,</span> <span class="alt">antiamebic</span> and <span class="alt">antimalarial drugs,</span> and <span class="alt">gallbladder dye</span> (if administered within 3 wk of test).
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Phenytoin</b> can lead to therapeutic failure. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed, 80% reaches systemic circulation. <span class="typehead">Peak:</span> 13 h. <span class="typehead">Distribution:</span> Enters cerebrospinal fluid. <span class="typehead">Metabolism:</span> Extensively metabolized to inactive metabolites. <span class="typehead">Elimination:</span> Excreted primarily in urine. <span class="typehead">Half-Life:</span> 0.81.5 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Patient is reexamined in 2 or 3 mo to ensure complete eradication of the infections.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not drive or operate other hazardous machinery on day of treatment or the following day because of potential drug-induced
            dizziness and drowsiness.
         </li>
<li>Usually, all schistosomal worms are dead 7 d following treatment.</li>
<li>Contact physician if you develop a sustained headache or high fever.</li>
<li>Do not breast feed while taking this drug without consulting physician (see <small>CONTRAINDICATIONS</small>).
         </li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>